HIMS
Hims & Hers Health, Inc. (HIMS)
Healthcare • Drug Manufacturers - Specialty & Generic • $32.84 • MCap: 7,601,070,592
🌐
https://www.hims.com • Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Buy Decision Core
Total Score
25
Business Quality
10
Financial Strength
7
Growth Outlook
1
Momentum
2
Price Action
Current
32.84
52W High
66.18
52W Low
14.52
Above 50DMA
29.84 (10.06%)
Above 200DMA
31.66 (3.74%)
Relative Strength
Relative Strength
-0.04
RS 3M
0.22
RS 6M
0.05
RS 9M
-0.39
RS 12M
-0.31
Fundamentals
Revenue Growth
0.04%
Earnings Growth
0%
ROE
-0.03%
ROA
0.01%
Valuation
PE (Fwd)
36.90
PEG
2.15
P/B
16.98
Upside
-13.45%
Risk
Beta
2.34
Short %
0.32
Risk Score
9.00
Analyst
Rating
hold
Target
28.42
Beta
2.34
Analysts
0
Total Score
25
Upside
-13.45%
Relative Strength
-0.04
Beta
2.34
Why Buy?
- Trading above 50 DMA
- Trading above 200 DMA
Key Risks
- Negative ROE
- High volatility (Beta > 1.5)
- Weak long-term relative strength
Score Breakdown
Business
10
10
Financial
7
7
Growth
1
1
Valuation
2
2
Risk
0
0
Momentum
2
2
Technical
52W High: 66.18
52W Low: 14.52
Above 50DMA: 10.06%
Above 200DMA: 3.74%
Valuation
Forward PE: 36.90
PEG: 2.15
P/B: 16.98
Upside: -13.45%
Risk
Beta: 2.34
Short Float: 0.32%
ROE: -0.03%
ROA: 0.01%